Cargando…

Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes

Pluripotent stem cells (PSCs) represent an appealing source from which to develop cell replacement therapies. Different initiatives have been launched to promote their development toward clinical applications. This article will review the main questions that should be considered before translating P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hulot, Jean-Sébastien, Stillitano, Francesca, Salem, Joe Elie, Kovacic, Jason C, Fuster, Valentin, Hajjar, Roger J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055070/ https://www.ncbi.nlm.nih.gov/pubmed/24405778 http://dx.doi.org/10.1186/scrt390

Ejemplares similares

Effectiveness of gene delivery systems for pluripotent and differentiated cells
por: Rapti, Kleopatra, et al.
Publicado: (2015)

Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells
por: Stillitano, Francesca, et al.
Publicado: (2017)

2525 Development of human cell-based screening assays to detect subject-specific drug-response variability
por: Stillitano, Francesca, et al.
Publicado: (2018)

Functional Human Beige Adipocytes From Induced Pluripotent Stem Cells
por: Guénantin, Anne-Claire, et al.
Publicado: (2017)

3444 Development of human engineered cardiac tissue (hECT)-based screening assay to explore cardiac contractile properties in response to pharmacological challenge with proarrhythmic drugs
por: Stillitano, Francesca, et al.
Publicado: (2019)

3213 Unraveling the role of Phospholamban (PLN) in humans via the characterization of Induced Pluripotent Stem Cell (iPSC) Cardiomyocytes (CM) derived from carriers of a lethal PLN mutation
por: Trivieri, Maria Giovanna, et al.
Publicado: (2019)

Modulation of chromatin remodeling proteins SMYD1 and SMARCD1 promotes contractile function of human pluripotent stem cell-derived ventricular cardiomyocyte in 3D-engineered cardiac tissues
por: Chow, Maggie Zi-Ying, et al.
Publicado: (2019)

Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells
por: Chen, Allen, et al.
Publicado: (2014)

Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells
por: James, Emma Claire, et al.
Publicado: (2021)

Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells
por: Ng, Kwong-Man, et al.
Publicado: (2014)

Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications
por: Di Baldassarre, Angela, et al.
Publicado: (2018)

Current protocols in the generation of pluripotent stem cells: theoretical, methodological and clinical considerations
por: Swelstad, Brad B, et al.
Publicado: (2009)

Importance of evaluating protein glycosylation in pluripotent stem cell-derived cardiomyocytes for research and clinical applications
por: Kelly, Maia I., et al.
Publicado: (2021)

Co-culture of induced pluripotent stem cells with cardiomyocytes is sufficient to promote their differentiation into cardiomyocytes
por: Chu, Axel J., et al.
Publicado: (2020)

Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes
por: Yang, Hao, et al.
Publicado: (2023)

Uses of cardiomyocytes generated from induced pluripotent stem cells
por: Lu, Tung-Ying, et al.
Publicado: (2011)

Atomic Force Mechanobiology of Pluripotent Stem Cell-Derived Cardiomyocytes
por: Liu, Jianwei, et al.
Publicado: (2012)

Maturation of pluripotent stem cell derived cardiomyocytes: The new challenge
por: Aigha, Idil, et al.
Publicado: (2016)

Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Park, Misun, et al.
Publicado: (2018)

Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes
por: Le, Minh Nguyen Tuyet, et al.
Publicado: (2019)

Partial Reprogramming of Pluripotent Stem Cell-Derived Cardiomyocytes into Neurons
por: Chuang, Wenpo, et al.
Publicado: (2017)

Mitochondrial Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes
por: Dai, Dao-Fu, et al.
Publicado: (2017)

In vitro effect of hydroxychloroquine on pluripotent stem cells and their cardiomyocytes derivatives
por: Kamga Kapchoup, Michelle Vanessa, et al.
Publicado: (2023)

Using human induced pluripotent stem cell-derived cardiomyocytes to understand the mechanisms driving cardiomyocyte maturation
por: Hamledari, Homa, et al.
Publicado: (2022)

Protocol to measure contraction, calcium, and action potential in human-induced pluripotent stem cell-derived cardiomyocytes
por: Zhang, Joe Z., et al.
Publicado: (2021)

Calcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Lee, Yee-Ki, et al.
Publicado: (2011)

Calcium Handling in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes
por: Itzhaki, Ilanit, et al.
Publicado: (2011)

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
por: Hoekstra, Maaike, et al.
Publicado: (2012)

Human Pluripotent Stem Cell-Derived Cardiomyocytes as Research and Therapeutic Tools
por: Acimovic, Ivana, et al.
Publicado: (2014)

Gata6 in pluripotent stem cells enhance the potential to differentiate into cardiomyocytes
por: Yoon, Chang-Hwan, et al.
Publicado: (2018)

Cytotoxicity of propofol in human induced pluripotent stem cell-derived cardiomyocytes
por: Kido, Koji, et al.
Publicado: (2017)

Bioengineering Approaches to Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Sun, Xuetao, et al.
Publicado: (2017)

Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes
por: Machiraju, Pranav, et al.
Publicado: (2019)

Human pluripotent stem cell-derived cardiomyocytes for studying energy metabolism()
por: Ulmer, Bärbel M., et al.
Publicado: (2020)

Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes
por: Wu, Peng, et al.
Publicado: (2021)

Scalable manufacturing of clinical‐grade differentiated cardiomyocytes derived from human‐induced pluripotent stem cells for regenerative therapy
por: Morita, Yuika, et al.
Publicado: (2022)

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications
por: Baghbaderani, Behnam Ahmadian, et al.
Publicado: (2015)

Biowire: a new platform for maturation of human pluripotent stem cell derived cardiomyocytes
por: Nunes, Sara S., et al.
Publicado: (2013)

Effects of Cryopreservation on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Assessing Drug Safety Response Profiles
por: Zhang, Joe Z., et al.
Publicado: (2020)

Trajectory reconstruction identifies dysregulation of perinatal maturation programs in pluripotent stem cell-derived cardiomyocytes
por: Kannan, Suraj, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m89tc42eo92fji2qui59odom9q